# Acrotech Biopharma Inc. – FDA Inspection, Nov 18, 2024

Source: https://www.keypedia.com/records/fda_inspections/acrotech-biopharma-inc/f0ec4968-f49d-4d2a-a936-12f0a2711b4b
Source feed: FDA_Inspections

> FDA inspection 1254819 of Acrotech Biopharma Inc., November 18, 2024. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 314. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1254819
- Company Name: Acrotech Biopharma Inc.
- Inspection Date: 2024-11-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 3

## Related Documents

- [FDA Inspection 1195306 - 2023-01-19](https://www.keypedia.com/records/fda_inspections/acrotech-biopharma-inc/d8adac73-ddbc-4993-a60b-4ef35c107440)

## Related Officers

- [Investigator](https://www.keypedia.com/people/mayar-m-mussa/4f39b1c8-93a6-4bc9-a800-5f802db48be6)

Company: https://www.keypedia.com/companies/acrotech-biopharma-inc/3311a997-8df4-4dc6-9137-27367ba84188

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248
